Detalhe da pesquisa
1.
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.
Blood
; 139(26): 3722-3731, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439295
2.
Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor-T cell therapy.
Eur J Haematol
; 112(1): 111-121, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37526606
3.
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Lancet Oncol
; 24(7): 811-822, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414012
4.
Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer.
Breast Cancer Res Treat
; 188(1): 91-99, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33797651
5.
Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy.
Biol Blood Marrow Transplant
; 26(1): 34-43, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605820
6.
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America.
Biol Blood Marrow Transplant
; 25(3): 599-605, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296479
7.
Effect of Turmeric Concentrations on the Rate of Growth of Oral Bacteria-An In-Vitro Study.
Dent J (Basel)
; 9(3)2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33804488
8.
Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.
Oral Oncol
; 123: 105626, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34801976